Molecular Characterization of Three Novel Large Deletions Causing α<sup>0</sup>-Thalassemia. [PDF]
Ferrer-Benito S +8 more
europepmc +1 more source
Myeloid neoplasm with eosinophilia associated with FIP1L1-PDGFRA presenting as femoral avascular necrosis: a rare case report. [PDF]
Frigotto KG +8 more
europepmc +1 more source
Howell-Jolly-like inclusions in granulocytes of a liver transplant recipient. [PDF]
Roldán Galiacho V +2 more
europepmc +1 more source
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials. [PDF]
González-Gil C +37 more
europepmc +1 more source
Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk. [PDF]
Marín-Quílez A +34 more
europepmc +1 more source
Reply to Omansen, T.F.; Ramharter, M. Intensive Therapeutic Plasma Exchange for Severe Yellow Fever: What Is the Evidence? Comment on "Ho et al. Intensive Therapeutic Plasma Exchange-New Approach to Treat and Rescue Patients with Severe Form of Yellow Fever. <i>Trop. Med. Infect. Dis.</i> 2025, <i>10</i>, 39". [PDF]
Ho YL +11 more
europepmc +1 more source
Cost-Effectiveness analysis of the 21-Gene platform for guiding treatment decisions for early Hormone-Positive breast cancer: the perspective of the Brazilian public health system. [PDF]
de Iracema Gomes Cubero D +5 more
europepmc +1 more source
Medicina, investigación y la industria farmacéutica: ¿una unión indisoluble? = Medicine, research and pharmaceutical industry: ¿an indissoluble union? [PDF]
Gutiérrez Aguirre, César Homero
core
Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. [PDF]
Silva N +5 more
europepmc +1 more source

